Your browser doesn't support javascript.
loading
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial.
Kraaijenhof, Jordan; Muskiet, Marcel H A; Tonneijck, Lennart; Ouwens, D Margriet; Kramer, Mark H H; van Raalte, Daniël H; Smits, Mark M.
Afiliação
  • Kraaijenhof J; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
  • Muskiet MHA; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
  • Tonneijck L; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
  • Ouwens DM; German Diabetes Center (DDZ), Leibniz Center for Diabetes Research, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
  • Kramer MHH; German Center for Diabetes Research (DZD), Muenchen-Neuherberg, Germany.
  • van Raalte DH; Department of Endocrinlogy, Ghent University Hospital, Ghent, Belgium.
  • Smits MM; Diabetes Centre, Department of Internal Medicine, Amsterdam University Medical Centers, location VUmc, Amsterdam, The Netherlands.
Diabetes Obes Metab ; 22(10): 1847-1856, 2020 10.
Article em En | MEDLINE | ID: mdl-32476255

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article